Study of CM310 in Subjects With Allergic Rhinitis

Clinical trial NCT05908032 · COMPLETED

Trial details

NCT number: NCT05908032
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2023-08-10
Primary completion: 2023-12-04
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.